A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro
release_abh72ntsmjdhfhfctic2kg5ixe
Entity Edit History
This table only shows accepted edits included in the catalog, not any work-in-progress.| Changelog | Editgroup | Description |
|---|---|---|
| #4537659
2020-06-02 01:02 |
crossref-bot
editgroup_hylt25nofzaidhf5o2gcy4orge
[view]
| Automated import of Crossref DOI metadata, harvested from REST API |